I have a SIP in following @ 1000 per month in each of following wef 2019

Axis long term equity fund
Aditya Birla sun Life equity advantage
Aditya Birla sun Life focussed equity
Franklin template Flexi cap
HDFC balanced advantage fund
SBI Small cap

Please suggest whether to continue or suggest some alternative.

Ans: These are good funds please continue, no need to switch or stop

Ans: These are good funds please continue, no need to switch or stop

Ans: These are good funds please continue, no need to switch or stop

Ans: In Large Cap: Axis Bluechip Fund - Growth is a better option

Too many Sectoral Funds; the risk of concentration is high; instead diversified funds are better option.

1. UTI Equity Fund – Growth
2. DSP mid cap Fund – Growth
3. Tata Large & Mid Cap Fund - Growth
4. Canara Robeco Emerging Equities – Growth

Above funds have decent exposure to Pharma, Banking and Technology

Rest of the funds are okay.

Ans: I recommend continuing with the "Mirae Asset Emerging Bluechip Fund" & "Parag Parikh Flexicap Fund" as these funds have good track record of performance and has generated returns that are above the benchmark index over a long period of time.

However, I recommend you to discontinue your investments in the following funds:

1. Axis Long Term Equity Fund- This fund has shown inconsistency in returns over a period of time and shows inconsistency in returns and its performance in comparison to its peers.

2. Nippon India Pharma Fund and Tata Digital India Fund- These are sectoral funds, which means that they invest in companies belonging to a single sector, pharma and technology respectively. Sectoral funds are exposed to higher risk than diversified funds, as their performance depends on the performance of a single sector. Additionally, sectoral funds are unlikely to generate returns that are significantly higher than the benchmark index, as they are passively managed and track a sector index.